Amphastar Pharmaceuticals Inc sell BiotechBee
Start price
07.07.24
/
50%
€35.11
Target price
07.07.25
€28.00
Performance (%)
-0.03%
End price
13.07.24
€35.10
Summary
This prediction ended on 13.07.24 with a price of €35.10. The SELL prediction by BiotechBee for Amphastar Pharmaceuticals Inc closed nearly unchanged from the start price. BiotechBee has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Amphastar Pharmaceuticals Inc | -6.435% | -6.435% | -49.400% |
| iShares Core DAX® | 0.734% | 1.458% | 17.980% |
| iShares Nasdaq 100 | -2.686% | -0.146% | 3.810% |
| iShares Nikkei 225® | -2.261% | -2.729% | 11.679% |
| iShares S&P 500 | -1.346% | 0.467% | 1.970% |
According to BiotechBee what are the pros and cons of Amphastar Pharmaceuticals Inc for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by BiotechBee for this prediction
In the thread Amphastar Pharmaceuticals Inc diskutieren
Sell mit Kursziel 28,0